Point72 Asset Management, L.P. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$21,792
-32.7%
811
-10.7%
0.00%
Q2 2023$32,379
-98.6%
908
-98.4%
0.00%
-100.0%
Q4 2022$2,297,805
-89.6%
56,652
-91.5%
0.01%
-90.9%
Q3 2022$22,031,000
+58.1%
666,600
+68.4%
0.09%
+49.2%
Q2 2022$13,939,000
-46.0%
395,868
-29.4%
0.06%
-42.2%
Q1 2022$25,805,000
+778.6%
561,100
+1166.8%
0.10%
+750.0%
Q4 2021$2,937,000
-70.7%
44,292
-72.4%
0.01%
-72.7%
Q3 2021$10,020,000
+116.4%
160,500
+187.1%
0.04%
+109.5%
Q2 2021$4,630,000
-91.9%
55,900
-95.8%
0.02%
-92.9%
Q3 2020$57,395,000
+11.7%
1,332,899
+12.0%
0.29%
-12.2%
Q2 2020$51,388,000
+30671.3%
1,189,807
+12979.1%
0.34%
+33400.0%
Q1 2019$167,000
+169.4%
9,097
+7.0%
0.00%
Q3 2016$62,000
-95.4%
8,500
-96.7%
0.00%
-100.0%
Q2 2016$1,362,000256,1010.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders